Epidermolysis Bullosa Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.EB-101 Treatment for New and Previously Treated Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Conditions: Epidermolysis Bullosa; Recessive Dystrophic Epidermolysis Bullosa; RDEB Intervention: Biological: EB-101 Surgical application of RDEB wounds Sponsor: Abeona Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2023 Category: Research Source Type: clinical trials
